16th World Congress on

Bioavailability & Bioequivalence

BABE-2020

Theme: BABE : Essential Innovation in Public and Medical Health

Welcome to ‘’16th World Congress on Bioavailability & Bioequivalence” which will be held during March 25-26, 2020 at Miami, USA. We invite all the researchers, delegate, students and healthcare professional to exchange ideas, knowledge at this global conference. This conference is based on the theme “BABE: Essential Innovation in Public and Medical Health”.

BABE 2020 provides a dynamic and energetic platform for understanding the spectrum of drug development and application in drug discovery, clinical trials, pharmacokinetics and pharmacology. A crucial component of abbreviated new drug application (ANDAs), leading to market access of safe, effective, and low cost in the advance studies of bioequivalence.

BABE 2020 Focus on all the Researchers, Principal Investigators, Experts working under academia and healthcare Industry, Business Delegates, Scientists and students across the Globe to provide an International forum for the dissemination of original research results, new Ideas and practical development Experiences.

Session 1: Drug Discovery

In pharmacology field, drug discovery is the process by which new candidate medication are discovered. modern drug discovery involves the identification of screening hits, medicinal chemistry and optimization those hits to increase the affinity, metabolic stability and oral bioavailability. The most important part of drug style involves the identification of characteristic diagnostic biomarkers like a macromolecule to blame for the malady or disorder and so developing a drug molecule of therapeutic efficiency that targets at it. Drug style depends on the data of the three-dimensional structure of building block targets. Drug metabolism is the term which is describe the biotransformation of pharmaceutical substances in the body so that they can be eliminated more easily. 

Bioavailability ConferenceBioequivalence ConferenceClinical Research ConferencesPharma Events

Related Conferences:

Bioavailability & Bioequivalence Summit, August 04-05, 2020, Toronto, Canada; International Pharmaceuticals & Technologies Event, February 25-27, 2020, Dubai, United Arab Emirates; 11th Annual Pharma Market Research Conference, February 5-6, 2020, Newark, USA; International Conference on Pharma Science Research & Development, February 24-26, 2020, Los Angeles, USA; International Conference on Pharmacy & Pharmaceutical Science, March 25-28, 2020, Tokyo, Japan.

Session 2: Bioavailability of Micronutrient and Bioactive Compounds

The bioavailability of macronutrients i.e. carbohydrates, proteins, fats are usually very high at more than 90% of the amount ingested. Micronutrients, i.e. vitamins and minerals, and bioactive phytochemicals (e.g. flavonoids, carotenoids) can vary widely in the extent they are absorbed and utilized. Bioactive compounds are phytochemicals found in food which can modulate metabolic process and resulting better health.

Biopharmaceutics CongressClinical Drug Discovery Meeting | Pharmacokinetic Congress | Bioavailability Meetings

Related Conferences:

International Conference on Drug Discovery & Development, February 17-18, 2020, Italy; International Conference on Clinical Pharmacy & Pharmacology, January 30, 2020, United States; International Conference on Veterinary Pharmacovigilance & Preclinical Safety Test, February 13, 2020, United Arab Emirates; International Conference on Pharmacovigilance & Clinical Trials, March 12, 2020, United States; International Conference on Biopharmaceutical Drugs & Pharmacovigilance, August 10, 2020, United States.

Session 3: Advancement of BA/BE

In pharmacology, BA is the subcategory of ingestion. BA is one of the huge mechanical gatherings of PK, as bioavailability considered when computing doses for non-intravenous courses of organization. It is the part of a managed measurement of unaltered medication that achieves the systemic flow.

Bioavailability ConferenceBioequivalence ConferenceClinical Research ConferencesPharma Events

Related Conferences:

International Conference on Pharmacovigilance & Public Health, September 24, 2020, United States; International Conference on PharmacovigilanceDrug Development & Testing, July 16, 2020, Canada; International Conference on Pharmacology & Pharmacovigilance System, January 09, 2020, Singapore; International Conference on Pharmacovigilance & Regulation of Medicines, September 10, 2020, Singapore; International Conference on Pharma & Pharmacovigilance, March 05, 2020, Spain; International Conference on Pharmacogenomics & Pharmacovigilance, June 11, 2020, Spain.

Session 4: Pharmacology-PK/PD

Pharmacology is the interaction between living organism and chemicals that affect the normal and abnormal biochemical reaction. PK and PD are the two areas of pharmacology. PK is the study of biochemical, physiological, molecular effects of drugs on cellular system and their mechanism of action, and PD is the study of bodily absorption, distribution, metabolism and excretion of drugs. pharmacologist use a variety of techniques to explain and manipulate the pharmacological action of substances for the health purpose.

Biopharmaceutics CongressClinical Drug Discovery Meeting | Pharmacokinetic Congress | Bioavailability Meetings

Related Conferences:

Bioavailability & Bioequivalence Summit, August 04-05, 2020, Toronto, Canada; International Pharmaceuticals & Technologies Event, February 25-27, 2020, Dubai, United Arab Emirates; 11th Annual Pharma Market Research Conference, February 5-6, 2020, Newark, USA; 2nd International Conference on Pharma Science Research & Development, February 24-26, 2020, Los Angeles, USA; 5th International Conference on Pharmacy & Pharmaceutical Science, March 25-28, 2020, Tokyo, Japan.

Session 5: Biosimilars and Biowaivers

Biosimilar segment is the one of the fastest growing segments. the growth of this sector is attribute to the positive outcomes ongoing clinical trials and the growing demand for biosimilar in different therapeutic application. The advance technologies like recombinant DNA technology, genetic engineering, has increased the entry of novel biopharmaceuticals in the market.

Bioavailability ConferenceBioequivalence ConferenceClinical Research ConferencesPharma Events

Related Conferences:

International Conference on Drug Discovery & Development, February 17-18, 2020, Italy; International Conference on Clinical Pharmacy & Pharmacology, January 30, 2020, United States; International Conference on Veterinary Pharmacovigilance & Preclinical Safety Test, February 13, 2020, United Arab Emirates; International Conference on Pharmacovigilance & Clinical Trials, March 12, 2020, United States; International Conference on Biopharmaceutical Drugs & Pharmacovigilance, August 10, 2020, United States.

Session 6: Pharmacovigilance

Pharmacovigilance also called drug safety, related to the collection, detection, assessment, monitoring, prevention of undesired harmful effect with pharmaceutical products. All things thought of, pharmacovigilance smartly centers around unfriendly medication responses, or ADRs, that are characterized as any reaction to a medicine which is harmful and causeless. Pharmacovigilance is disquieted regarding characteristic the hazards associated with pharmaceutical things and with limiting the danger of any harm that will come back to patients. Organizations should direct an intensive medication security and pharmacovigilance review to survey their consistency with overall laws, controls, and direction.

Biopharmaceutics CongressClinical Drug Discovery Meeting | Pharmacokinetic Congress | Bioavailability Meetings

Related Conferences:

International Conference on Pharmacovigilance & Public Health, September 24, 2020, United States; International Conference on PharmacovigilanceDrug Development & Testing, July 16, 2020, Canada; International Conference on Pharmacology & Pharmacovigilance System, January 09, 2020, Singapore; International Conference on Pharmacovigilance & Regulation of Medicines, September 10, 2020, Singapore; International Conference on Pharma & Pharmacovigilance, March 05, 2020, Spain; International Conference on Pharmacogenomics & Pharmacovigilance, June 11, 2020, Spain.

Session 7: Bioequivalence-In Vivo/In Vitro

In pharmacokinetics bioequivalence used to access in vivo biological equivalence of two proprietary preparations of a drug. Human pharmacokinetic in vivo studies are often presumed to serve as the “gold standard” to assess product bioequivalence (BE) of immediate-release (IR) solid oral dosage forms. Sponsors of potential in vivo human pharmacokinetic BE testing should be required to justify why in vitro data is insufficient, similar to proposed animal testing requires justification to not employ an in vitro approach.

Bioavailability ConferenceBioequivalence ConferenceClinical Research ConferencesPharma Events

Related Conferences:

Bioavailability & Bioequivalence Summit, August 04-05, 2020, Toronto, Canada; International Pharmaceuticals & Technologies Event, February 25-27, 2020, Dubai, United Arab Emirates; 11th Annual Pharma Market Research Conference, February 5-6, 2020, Newark, USA; 2nd International Conference on Pharma Science Research & Development, February 24-26, 2020, Los Angeles, USA; 5th International Conference on Pharmacy & Pharmaceutical Science, March 25-28, 2020, Tokyo, Japan.

Session 8: Emerging Bioavailability and Bioequivalence

Historically, the development of bio analytical approach in the 1960s and 1970s was allowed for the first time, the measurement of very low levels of drug concentrations in biological fluids. pharmacokinetic profiles of drugs, describing absorption, distribution, and clearance, could be determined. Regulations related to bioavailability and bioequivalence were put into place, considering the latest advances in the science. A significant role in the discovery, development, and regulation of new drug products involves in recent research of Bioavailability and Bioequivalence.

Biopharmaceutics CongressClinical Drug Discovery Meeting | Pharmacokinetic Congress | Bioavailability Meetings

Related Conferences:

International Conference on Drug Discovery & Development, February 17-18, 2020, Italy; International Conference on Clinical Pharmacy & Pharmacology, January 30, 2020, United States; International Conference on Veterinary Pharmacovigilance & Preclinical Safety Test, February 13, 2020, United Arab Emirates; International Conference on Pharmacovigilance & Clinical Trials, March 12, 2020, United States; International Conference on Biopharmaceutical Drugs & Pharmacovigilance, August 10, 2020, United States.

Session 9: Biopharmaceutics Application and Clinical Pharmacology

Clinical pharmacology based on drug in human and their optimal clinical use in patient. It is at the key interface that the discipline of bio pharmaceutics has emerged. The past two decades have witnessed considerable advances in bio pharmaceutics particularly with regard to bioavailability and bioequivalence, as they relate to product quality and regulatory standards of approval.

Bioavailability ConferenceBioequivalence ConferenceClinical Research ConferencesPharma Events

Related Conferences:

International Conference on Pharmacovigilance & Public Health, September 24, 2020, United States; International Conference on PharmacovigilanceDrug Development & Testing, July 16, 2020, Canada; International Conference on Pharmacology & Pharmacovigilance System, January 09, 2020, Singapore; International Conference on Pharmacovigilance & Regulation of Medicines, September 10, 2020, Singapore; International Conference on Pharma & Pharmacovigilance, March 05, 2020, Spain; International Conference on Pharmacogenomics & Pharmacovigilance, June 11, 2020, Spain.

Session 10: Vaccine, Blood and Biologics

Biologics are the natural products isolated from human, animal, or microorganisms.it can be composed of sugars, proteins, or living cells and tissues. Biologics mainly include recombinant protein, tissue, genes, allergens, cells, blood component, blood, vaccine.it is used to treat numerous diseases and conditions.Biological products often represent the cutting edge of biomedical research and offer the most effective means to treat variety of medical illness and condition that presently have no other treatments available.

Biopharmaceutics CongressClinical Drug Discovery Meeting | Pharmacokinetic Congress | Bioavailability Meetings

Related Conferences:

Bioavailability & Bioequivalence Summit, August 04-05, 2020, Toronto, Canada; International Pharmaceuticals & Technologies Event, February 25-27, 2020, Dubai, United Arab Emirates; 11th Annual Pharma Market Research Conference, February 5-6, 2020, Newark, USA; 2nd International Conference on Pharma Science Research & Development, February 24-26, 2020, Los Angeles, USA; 5th International Conference on Pharmacy & Pharmaceutical Science, March 25-28, 2020, Tokyo, Japan.

Session 11: Pharmaceutical Formulation

Pharmaceutical formulation is the design of drugs form.it describes the various forms in which drugs supplied to doctors, patients and veterinary surgeons. It is mainly based on solid, liquid, and paste formulations, controlled drug release, the stability of formulations, the importance of the container of the formulation, and large-scale manufacturing of formulated products.

Bioavailability ConferenceBioequivalence ConferenceClinical Research ConferencesPharma Events

Related Conferences:

International Conference on Drug Discovery & Development, February 17-18, 2020, Italy; International Conference on Clinical Pharmacy & Pharmacology, January 30, 2020, United States; International Conference on Veterinary Pharmacovigilance & Preclinical Safety Test, February 13, 2020, United Arab Emirates; International Conference on Pharmacovigilance & Clinical Trials, March 12, 2020, United States; International Conference on Biopharmaceutical Drugs & Pharmacovigilance, August 10, 2020, United States.

Bioavailability refers to the extent and rate at which the active drug enters systemic circulation, thereby accessing the site of action. Bioequivalence indicates the in vivo biological equivalence of two proprietary preparation of a drugs. The pharmaceutical industry is engaged in researching, developing, manufacturing, and distributing drugs for human or veterinary use.

Many countries have established several procedures for the introduction of generic of pharmaceutical products. New drugs have an enormous positive influence on global health, prosperity and economic productivity by saving lives, increasing life spans, reducing suffering, preventing surgeries and shortening hospital stays. The concept of bioavailability/bioequivalence plays an important role in drug research and development, especially in the generic-drug industry. The worldwide market for pharmaceuticals is projected to grow around $1.3 trillion by 2020, representing an annual growth rate of 4.9 per cent.

USA is well-developed pharmaceutical market and offers universal health coverage to its citizens. In 1984, United States Congress passed the “Drug Price Competition and Patent Term Restoration Act of 1984” that authorized FDA to approve generic drug products through BA and BE studies. As a result of the passage of this act, several activities were initiated by the FDA for the review and approval of generic drug application. The U.S. pharmaceutical market is the world’s most important national market.Together with Canada and Mexico, it represents the largest continental pharma market worldwide. 

The U.S. pharmaceutical industry is one of the most competitive sectors in the economy. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), more than 810,000 people work in the biopharmaceutical industry in the United States across a broad range of occupations, such as scientific research, technical support and manufacturing. Directly and indirectly, the industry supports over 3.4 million jobs across the United States. Although manufacturing jobs supported by the industry are expected to decline over the next decade due to continued productivity gains, it will remain an important source of high paying jobs, providing salaries way above the national average.

The global market for generic drugs should reach $533 billion by 2021 from $352 billion in 2016 at a compound annual growth rate (CAGR) of 8.7%, from 2016 to 2021. 2010, total medicine expenditure in the United States was approximately 316 billion U.S. dollars. As of 2018, this amount increased to around 482 billion U.S. dollars. 60 billion U.S. dollars are spent annually on pharmaceutical R&D purposes in the United States. 

Societies Associated with Pharmaceutical Technology and Development around the globe:

America:

American Association of Pharmaceutical Scientists

American Association of Colleges of Pharmacy

American Pharmacists Association

American Society of Consultant Pharmacists

American Society of Health-System Pharmacists

National Association of Chain Drug Stores

National Community Pharmacists Association

Indo- American Pharmaceutical Society

International Pharmaceutical Federation (FIP)

American Society for Automation in Pharmacy

Europe:

National Pharmacy Association

Pharmaceutical Society of Northern Ireland

Royal Pharmaceutical Society

Norwegian Pharmacy Association

Pharmaceutical Society of Ireland

Danish Association of Pharmaconomists

European Association of Employed Community Pharmacists

Pharmaceutical Group of the European Union

European Society of Clinical Pharmacy

Austrian Pharmaceutical Society

European Association of Employed Community Pharmacists in Europe (EPhEU)

European Pharmaceutical Union (EPU)

Pharmaceutical Group of the European Union (PGEU)

National Pharmacy Association

Royal Pharmaceutical Society (RPS)

German Pharmaceutical Society

Asia Pacific:

American Association of Pharmaceutical Scientists (AAPS)

British Columbia Pharmacy Association

Canadian Pharmacists Association (CPhA)

Drug Information Association

Kuwait Pharmaceutical Association

National Pharmaceutical Association

Ohio Pharmacists Association

Pharmaceutical Society of Australia

Pharmaceutical Society of Korea

South Carolina Pharmacy Association

Universities around the Globe:

America:

California Health Science University, USA

Marshall B. Ketchum University, USA 

University of California, San Francisco, USA 

University of Georgia, USA

Western University of Health Sciences, USA 

University of Colorado Denver, USA

University of Connecticut, USA

University of Florida, USA

Nova Southeastern University, USA

University of Florida, USA

Drake University-Iowa, USA

Europe:

Freie University of Berlin, Germany

Braunschweig University of Technology, Germany

Goethe University Frankfurt, Germany

Joseph Fourier University, France

University of Bologna, Italy

Aston University, United Kingdom

University of Barcelona, Spain

Humboldt University of Berlin, Germany

University of Hamburg, Germany

Middle East-

Sultan Qaboos University, Oman

Jordan University of Science and Technology, Jordan

United Arab Emirates University, UAE

King Saud University, Saudi Arabia

King AbdulAziz University, Saudi Arabia

Qatar University, Qatar

Alfaisal University, Saudi Arabia

American University of Beirut, Lebanon

Sidi Mohamed Ben Abdellah University, Morocco

Asia pacific:

University of Tokyo, Japan

National University of Singapore, Singapore

Kyoto University, Japan

University of Hong Kong, Hong Kong

Peking University, China

Seoul National University, South Korea

National Taiwan University, Taiwan

Osaka University, Japan

Tsinghua University, China

Conclusion

Integrative biology, chemical biology/biological chemistry, Pharmacogenetics, experimental medicine and systems biology are more focused disciplines. Pharmacology helps us to understand from molecular level how drugs are working. The essence of pharmacology is trying to understand how to make drugs precisely effective, safe and establish how they work.

References 

https://blog.marketresearch.com/the-growing-pharmaceuticals-market-expert-forecasts-and-analysis

http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm.

https://www.statista.com/topics/1412/drug-store-pharmacy-market-in-the-us/

  • Drug Discovery
  • Bioavailability of Micronutrient and Bioactive compounds
  • Advancements in BA and BE
  • Pharmacology: PK & PD
  • Biosimilars & Biowaivers
  • Pharmacovigilance
  • Bioequivalence Protocol: In-Vitro / In-Vivo Studies
  • Emerging Bioavailability & Bioequivalence Studies
  • Biopharmaceutics Applications & Clinical Pharmacology
  • Vaccines, Blood & Biologics
  • Pharmaceuticals Formulation

5 Organizing Committee Members

Media Partners & Collaborations

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner